Serial PET MPI in Patients Undergoing Cancer Treatment

Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.

NCT03202199 ·Status: UNKNOWN ·Phase: NA

Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation

NCT00894101 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

NCT03295695 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1

Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer

NCT04999917 ·Status: COMPLETED ·Phase: NA

Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET

NCT00904410 ·Status: COMPLETED ·Phase: PHASE4

Hybrid PET/CT in Cancer Patients

NCT00396916 ·Status: COMPLETED ·Phase: NA

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

NCT06566209 ·Status: TERMINATED

Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors

NCT04841421 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression

NCT01604512 ·Status: COMPLETED ·Phase: NA

PET/CT to Identify "Vulnerable" Arterial Plaque

NCT00416065 ·Status: UNKNOWN ·Phase: NA

Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)

NCT01308905 ·Status: UNKNOWN ·Phase: NA

Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy

NCT06976021 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation

NCT00847509 ·Status: COMPLETED ·Phase: NA

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

NCT04151940 ·Status: RECRUITING ·Phase: NA

FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents

NCT02055586 ·Status: COMPLETED

PET Study With [89Zr]-Df-CriPec® Docetaxel

NCT03712423 ·Status: COMPLETED ·Phase: PHASE1

Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection

NCT05513027 ·Status: TERMINATED ·Phase: NA

PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer

NCT01712815 ·Status: TERMINATED ·Phase: NA

The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers

NCT00230269 ·Status: COMPLETED

MPDL3280A-imaging-IST-UMCG

NCT02453984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

NCT00935090 ·Status: RECRUITING

Molecular Imaging and Spectroscopy With Stable Isotopes in Oncology and Neurology

NCT03526809 ·Status: UNKNOWN

PET/MRI Perfusion and CT Perfusion in Solid Tumors

NCT02314962 ·Status: TERMINATED

A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

NCT05629689 ·Status: RECRUITING ·Phase: PHASE1

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

NCT04316117 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2